Low-level resistance to rifampin in Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 3, 2003, Pages 863-868

  Meier, Patricia Stutzmann ^a   Utz, Silvia ^a   Aebi, Suzanne ^a   Mühlemann, Kathrin ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM MUTANT; CONCENTRATION RESPONSE; DRUG SENSITIVITY; GENE CLUSTER; GENE MAPPING; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

ANTIBIOTICS, ANTITUBERCULAR; DNA, BACTERIAL; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MUTATION; PNEUMOCOCCAL INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIFAMPIN; STREPTOCOCCUS PNEUMONIAE; TRANSFORMATION, BACTERIAL;

EID: 0037416974     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.3.863-868.2003     Document Type: Article

References (23)

1. Adam, D. 2002. Global antibiotic resistance in Streptococcus pneumoniae. J. Antimicrob. Chemother. 50:1-5.
2. Aubry-Damon, H., C. J. Soussy, and P. Courvalin. 1998. Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 42:2590-2594.
3. Band, J., D. Fraser, and G. Ajello. 1984. Prevention of Haemophilus influenzae type b disease. JAMA 251:2381-2386.
4. Chambers, H. 1988. Methicillin-resistant staphylococci. Clin. Microbiol. Rev. 1:173-186.
5. Dabbs, E. R., K. Yazawa, Y. Mikami, M. Miyaji, N. Morisaki, S. Iwasaki, and K. Furihata. 1995. Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation. Antimicrob. Agents Chemother. 39:1007-1009.
6. Deal, W., and E. Sanders. 1969. Efficacy of rifampicin in treatment of meningococcal carriers. N. Engl. J. Med. 281:641-645.
7. Doern, G. V., A. Brueggemann, H. P. Holley, Jr., and A. M. Rauch. 1996. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob. Agents Chemother. 40:1208-1213.
8. Enright, M., P. Zawadzki, P. Pickerill, and C. Dowson. 2000. Molecular evolution of rifampicin resistance in Streptococcus pneumoniae. Microb. Drug. Resist. 4:65-70.
9. Faden, H., R. Duffy, R. Wasielewski, J. Wolf, D. Krystofik, and Y. Tung. 1997. Relationship between nasopharyngeal colonization and the development of otitis media in children. J. Infect. Dis. 175:1440-1445.
10. Friedland, I., and G. H. McCracken, Jr. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-382.
11. Hetherington, S. V., A. S. Watson, and C. C. Patrick. 1995. Sequence and analysis of the rpoB gene of Mycobacterium smegmatis. Antimicrob. Agents Chemother. 39:2164-2166.
12. Jin, D., and C. Gross. 1988. Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J. Mol. Biol. 202:45-58.
13. John, C. 1994. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin. Infect. Dis. 18:188-193.
14. Klugman, K. P., I. R. Friedland, and J. S. Bradley. 1995. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob. Agents Chemother. 39:1988-1992.
15. Linares, J., R. Pallares, T. Alonso, J. Perez, J. Ayats, F. Gudiol, P. Viladrich, and R. Martin. 1992. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin. Infect. Dis. 15:99-105.
16. Majewski, J., P. Zawadzki, P. Pickerill, F. M. Cohan, and C. G. Dowson. 2000. Barriers to genetic exchange between bacterial species: Streptococcus pneumoniae transformation. J. Bacteriol. 182:1016-1023.
17. Mühlemann, K., H. Matter, M. Tauber, and T. Bodmer. Nationwide sentinel surveillance of nasopharyngeal S. pneumoniae in Switzerland 1998-99. J. Infect. Dis., in press.
18. Padayachee, T., and K. P. Klugman. 1999. Molecular basis of rifampin resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43: 2361-2365.
19. Sessegolo, J., A. Levin, C. Levy, M. Asensi, R. Facklam, and L. Teixeira. 1994. Distribution of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated in Brazil from 1988 to 1992. J. Clin. Microbiol. 32:906-911.
20. R mutations in the beginning of the Escherichia coli rpoB gene. Mol. Gen. Genet. 244:120-126.
21. Stefanelli, P., C. Fazio, G. La Rosa, C. Marianelli, M. Muscillo, and P. Mastrantonio. 2001. Rifampicin-resistant meningococci causing invasive disease: detection of point mutations in the rpoB gene and molecular characterization of the strains. J. Antimicrob. Chemother. 47:219-222.
22. Tanaka, Y., K. Yazawa, E. Dabbs, K. Nishikawa, H. Komaki, Y. Mikami, M. Miyaji, N. Morisaki, and S. Iwasaki. 1996. Different rifampicin inactivation mechanisms in Nocardia and related taxa. Mol. Microbiol. 40:1-4.
23. van Tilburg, P., D. Bogaert, M. Sluitjer, A. Jansz, R. de Groot, and P. Hermans. 2001. Emergence of rifampin-resistant Streptococcus pneumoniae as a result of antimicrobial therapy for penicillin-resistant strains. Clin. Infect. Dis. 33:93-96.